Search Results - "Khater, Bashar"

IBCL-506 Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Saleh, Othman, Al-Hawi, Omar, Aldemerdash, Mohamed A., Alnajjar, Roa'a, Khaity, Abdulrhman, Al-Hawi, Omar

“…Rituximab is the standard therapy after chemotherapy induction for newly diagnosed non-Hodgkin lymphoma (NHL) patients. Recent evidence suggests…”
Get full text

Increased rhinovirus/enterovirus infections including Ev-D68 in the United States, a challenge for healthcare providers amidst influenza virus infection and the COVID-19 pandemic by Abdul-Rahman, Toufik, Nazir, Abubakar, Khater, Bashar, Pyrpyris, Nikolaos, Wireko, Awuah A, Miteu, David G, Patel, Heli, Sikora, Vladyslav

“…In March 2020, WHO declared SARS-CoV-2 a global pandemic and lockdowns were enforced in most of the United States. Self-protective measures and travel…”
Get full text

IBCL-523 Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

“…Rituximab is considered a mainstay of treatment for non-Hodgkin lymphoma (NHL) that is usually given intravenously. A subcutaneous formulation is proposed as…”
Get full text

Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text

Safety and Efficacy of Ibritumomab Tiuxetan Versus Rituximab in Newly Diagnosed and Relapsed Patients With Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Saleh, Othman, Al-Hawi, Omar, Abdallah, Mohamed, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text

Comparative Efficacy, Safety, and Cost-Effectiveness of Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma: A Systematic Review and Meta-Analysis by Albakri, Khaled, Khater, Bashar, Aldemerdash, Mohamed A., Nasruldin Shahin, Hatim, Aldemerdash, Ahmed, Saleh, Othman, Nabeel Alsafuti, Mohammad, Alnajjar, Roa'a, Khaity, Abdulrhman, Ammari, Omar

Get full text